nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlordiazepoxide—Loxapine—ADRA1B—polycystic ovary syndrome	0.125	0.237	CrCbGaD
Chlordiazepoxide—Amoxapine—ADRA1A—polycystic ovary syndrome	0.108	0.204	CrCbGaD
Chlordiazepoxide—Clozapine—ADRA1B—polycystic ovary syndrome	0.105	0.199	CrCbGaD
Chlordiazepoxide—Loxapine—ADRA1A—polycystic ovary syndrome	0.0844	0.159	CrCbGaD
Chlordiazepoxide—Clozapine—ADRA1A—polycystic ovary syndrome	0.0709	0.134	CrCbGaD
Chlordiazepoxide—Clozapine—CYP1A1—polycystic ovary syndrome	0.0361	0.0682	CrCbGaD
Chlordiazepoxide—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00662	0.0141	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00649	0.0138	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00637	0.0136	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00626	0.0133	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00622	0.0132	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00611	0.013	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Ion channel transport—TRPV6—polycystic ovary syndrome	0.0059	0.0126	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Ion channel transport—SCNN1A—polycystic ovary syndrome	0.00534	0.0114	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00513	0.0109	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00469	0.00999	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00448	0.00954	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00433	0.00922	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00433	0.00921	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Orphan transporters—PLAT—polycystic ovary syndrome	0.00369	0.00786	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00362	0.0077	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00361	0.00768	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Orphan transporters—PLAT—polycystic ovary syndrome	0.00359	0.00764	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Orphan transporters—PLAT—polycystic ovary syndrome	0.00352	0.0075	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.0035	0.00746	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00348	0.00741	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Orphan transporters—PLAT—polycystic ovary syndrome	0.00346	0.00737	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00344	0.00732	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Orphan transporters—PLAT—polycystic ovary syndrome	0.00344	0.00732	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00338	0.0072	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Orphan transporters—PLAT—polycystic ovary syndrome	0.00338	0.00719	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00336	0.00715	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.0033	0.00702	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00321	0.00684	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.00316	0.00673	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00312	0.00665	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00309	0.00658	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00307	0.00653	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00301	0.00641	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00299	0.00637	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Orphan transporters—PLAT—polycystic ovary syndrome	0.00295	0.00629	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00294	0.00626	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.00288	0.00614	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00284	0.00605	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00283	0.00602	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00276	0.00588	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00271	0.00577	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00269	0.00572	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00267	0.00567	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00265	0.00563	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.0026	0.00553	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00257	0.00548	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00257	0.00547	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CAMK2D—polycystic ovary syndrome	0.00257	0.00547	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00253	0.00539	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.0025	0.00532	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.0025	0.00532	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00245	0.00522	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00242	0.00514	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00241	0.00513	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00239	0.0051	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00237	0.00505	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00237	0.00503	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00236	0.00501	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00235	0.005	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00235	0.005	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—NGFR—polycystic ovary syndrome	0.00233	0.00497	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00232	0.00495	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00232	0.00495	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00231	0.00491	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00227	0.00484	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—polycystic ovary syndrome	0.00227	0.00484	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00227	0.00482	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00226	0.00481	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00225	0.00479	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00222	0.00472	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00221	0.0047	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00219	0.00465	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00218	0.00464	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00217	0.00461	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00214	0.00455	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00213	0.00453	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00208	0.00442	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00206	0.00437	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00205	0.00437	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00204	0.00434	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00201	0.00427	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.002	0.00426	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00199	0.00424	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00195	0.00416	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—CAMK2D—polycystic ovary syndrome	0.00193	0.00411	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00191	0.00406	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00186	0.00397	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.00186	0.00396	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00185	0.00394	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00184	0.00391	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—CAMK2D—polycystic ovary syndrome	0.0018	0.00383	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00179	0.0038	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00177	0.00376	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00174	0.00369	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00172	0.00367	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmission across Chemical Synapses—DLG4—polycystic ovary syndrome	0.00171	0.00364	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00169	0.0036	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00166	0.00353	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Neuronal System—DLG4—polycystic ovary syndrome	0.00164	0.00348	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00163	0.00348	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—IRS2—polycystic ovary syndrome	0.00163	0.00347	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Neuronal System—DLG4—polycystic ovary syndrome	0.00159	0.00339	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Neuronal System—DLG4—polycystic ovary syndrome	0.00156	0.00332	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00155	0.0033	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00154	0.00328	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Neuronal System—DLG4—polycystic ovary syndrome	0.00154	0.00327	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Neuronal System—DLG4—polycystic ovary syndrome	0.00153	0.00325	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00152	0.00323	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00151	0.00322	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.00151	0.00321	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.0015	0.0032	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Neuronal System—DLG4—polycystic ovary syndrome	0.0015	0.00319	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00148	0.00316	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—CAMK2D—polycystic ovary syndrome	0.00148	0.00315	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00144	0.00307	CbGpPWpGaD
Chlordiazepoxide—GABRB3—BDNF signaling pathway—IRS1—polycystic ovary syndrome	0.00142	0.00303	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00134	0.00286	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00132	0.00281	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Neuronal System—DLG4—polycystic ovary syndrome	0.00131	0.00279	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00125	0.00266	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00123	0.00262	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00122	0.00259	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00122	0.00259	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.00121	0.00259	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00121	0.00259	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.0012	0.00256	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00117	0.00249	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00112	0.00238	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00109	0.00232	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00108	0.00229	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.00102	0.00216	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00101	0.00216	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.001	0.00213	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000988	0.0021	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000982	0.00209	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00097	0.00206	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000969	0.00206	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000943	0.00201	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000926	0.00197	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00091	0.00194	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000908	0.00193	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000904	0.00192	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000902	0.00192	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000887	0.00189	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000876	0.00186	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000863	0.00184	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00086	0.00183	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000846	0.0018	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00084	0.00179	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000825	0.00176	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000825	0.00176	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000805	0.00171	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000803	0.00171	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000801	0.00171	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000796	0.00169	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000794	0.00169	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000792	0.00168	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000787	0.00167	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000776	0.00165	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000773	0.00165	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000768	0.00164	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000754	0.00161	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000732	0.00156	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000721	0.00153	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000713	0.00152	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000703	0.0015	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000693	0.00148	CbGpPWpGaD
Chlordiazepoxide—GABRB2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000692	0.00147	CbGpPWpGaD
Chlordiazepoxide—GABRA5—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000673	0.00143	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000664	0.00141	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000663	0.00141	CbGpPWpGaD
Chlordiazepoxide—GABRA3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.00066	0.00141	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000659	0.0014	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000654	0.00139	CbGpPWpGaD
Chlordiazepoxide—GABRA2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000649	0.00138	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000647	0.00138	CbGpPWpGaD
Chlordiazepoxide—GABRB3—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000645	0.00137	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000638	0.00136	CbGpPWpGaD
Chlordiazepoxide—GABRG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000633	0.00135	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000594	0.00126	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000569	0.00121	CbGpPWpGaD
Chlordiazepoxide—GABRA1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000553	0.00118	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000525	0.00112	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.00052	0.00111	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.00052	0.00111	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000518	0.0011	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000484	0.00103	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000482	0.00103	CbGpPWpGaD
Chlordiazepoxide—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000479	0.00102	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000423	0.0009	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000417	0.000888	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000411	0.000876	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000411	0.000876	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000372	0.000792	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000345	0.000734	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.00034	0.000724	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.00034	0.000724	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000327	0.000696	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000316	0.000673	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000315	0.000671	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000312	0.000664	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000278	0.000591	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000269	0.000572	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000269	0.000572	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000265	0.000564	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000242	0.000515	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000236	0.000503	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000229	0.000487	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000225	0.00048	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000214	0.000455	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000211	0.000448	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000204	0.000434	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000204	0.000434	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000197	0.000418	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000189	0.000402	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000187	0.000397	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000182	0.000387	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000176	0.000375	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000173	0.000369	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000173	0.000369	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	0.000158	0.000336	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000154	0.000329	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.00015	0.000319	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	0.00015	0.000318	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000146	0.000311	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000138	0.000293	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	0.000137	0.000292	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	0.000133	0.000284	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	0.000129	0.000274	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	0.000124	0.000263	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	0.000123	0.000261	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000122	0.00026	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	0.000117	0.000248	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000115	0.000245	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000241	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000111	0.000235	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	0.000103	0.00022	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	9.81e-05	0.000209	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	9.54e-05	0.000203	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	8.97e-05	0.000191	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	8.36e-05	0.000178	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	8.25e-05	0.000176	CbGpPWpGaD
Chlordiazepoxide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	8.2e-05	0.000175	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	8.01e-05	0.00017	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	7.63e-05	0.000162	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	7.23e-05	0.000154	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	6.74e-05	0.000144	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	5.47e-05	0.000116	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	5.39e-05	0.000115	CbGpPWpGaD
Chlordiazepoxide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	5.36e-05	0.000114	CbGpPWpGaD
